Anthem Biosciences Ltd.
Industry:
Pharmaceuticals & Drugs
Issue Details
Open Date
14 Jul 2025Close Date
16 Jul 2025Size (in Crs.)
-
Size (Shares)
-Listing On
BSE, NSE
Issue Terms
Price Range
0Lot Size
-
Type
Book building
Face Value
2
Market Lot
1
Objective of the Issue
(i) to carry out the Offer for Sale of up to [?] Equity Shares of face value of ? 2 each by theSelling Shareholders aggregating up to ? 33,950.00 million; and(ii) achieve the benefits of listing the Equity Shares on the Stock Exchanges.
Description
We are an innovation-driven and technology-focused Contract Research, Development and Manufacturing Organization(“CRDMO”) with fully integrated operations spanning across drug discovery, development and manufacturing. We are one ofthe few companies in India with integrated New Chemical Entity (“NCE”) and New Biological Entity (“NBE”) capabilitiesacross drug discovery, development, and commercial manufacturing, according to the F&S Report. As a one-stop serviceprovider, we serve a range of customers, encompassi... Show More
Address
No. 49, F1 & F2, Canara Bank Road , Bommasandra Industrial Area , Phase I, Bommasandra
Bengaluru
560099
Promoter Holding
Promoters:
Ajay Bhardwaj, Ganesh Sambasivam, Ishaan Bhardwaj, K Ravindra Chandrappa
Total Share Capital
431747949
Offered to Public
-
% Promoter's Holding (Pre-Issue)
77.23
% Promoter's Holding (Post-Issue)
-
Shares on offer
Total Share Offer
431747949
Of above offred to public
-
Post Issue shares
NA
Post Issue Promoters
-
Lead Managers to the Issue:
Citigroup Global Markets India Pvt Ltd., JM Financial Ltd., JP Morgan India Pvt Ltd, Nomura Financial Advisory & Securities (India) Pvt Ltd.
Registrar Details
Registrar Name:
K FIN Technologies Ltd.-(Karvy Fintech Pvt Ltd.)
Address
Karvy Selenium Tower B, Plot 31-32 , Gachibowli,Financial District , Nanakramguda , Hyderabad
500032